Genoway Cash Flow-to-Debt Ratio
Genoway cash flow-to-debt ratio. Genoway (ALGEN) has a Cash Flow-to-Debt Ratio of -0.14x as of June 2025, meaning its operating cash flow of €-2.80 Million could theoretically repay 0% of its total liabilities (€20.43 Million) in one year. Check ALGEN cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Genoway (2009–2024)
Cash flow-to-debt ratio of Genoway from 2009 to 2024. Historical debt coverage capacity for Genoway across 16 annual periods. Check ALGEN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Genoway Cash Flow-to-Debt Ratio by Year (2009–2024)
Genoway cash flow-to-debt ratio by year from 2009 to 2024. Year-by-year debt coverage analysis for Genoway. For the full cash flow conversion analysis, see cash flow conversion of Genoway.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.41x | €5.38 Million | €13.23 Million | ▲ +92.1% |
| 2023 | 0.21x | €3.06 Million | €14.46 Million | ▲ +50.7% |
| 2022 | 0.14x | €2.36 Million | €16.76 Million | ▲ +549.2% |
| 2021 | -0.03x | €-561.34K | €17.94 Million | ▼ -253.6% |
| 2020 | -0.01x | €-164.33K | €18.57 Million | ▼ -109.2% |
| 2019 | 0.10x | €1.18 Million | €12.31 Million | ▲ +33.5% |
| 2018 | 0.07x | €847.03K | €11.80 Million | ▲ +15.4% |
| 2017 | 0.06x | €620.94K | €9.98 Million | ▲ +144.5% |
| 2016 | -0.14x | €-901.83K | €6.44 Million | ▼ -200.3% |
| 2015 | 0.14x | €851.08K | €6.10 Million | ▲ +264.5% |
| 2014 | 0.04x | €200.29K | €5.23 Million | ▼ -79.1% |
| 2013 | 0.18x | €852.87K | €4.64 Million | ▲ +161.6% |
| 2012 | -0.30x | €-1.70 Million | €5.70 Million | ▼ -332.2% |
| 2011 | 0.13x | €741.51K | €5.78 Million | ▼ -4.0% |
| 2010 | 0.13x | €914.07K | €6.83 Million | ▼ -45.5% |
| 2009 | 0.25x | €1.80 Million | €7.35 Million | — |